One of them is miR‐18b, which upregulates p53 by downregulating mouse double minute 2 homolog (MDM2); miR‐18b was found to be downregulated in melanoma compared with benign nevi and its downregulation was responsible for decreased p53 activity (Dar et al., 2013). This evidence concerns the gene TP53 and melanoma.